Intrahepatic cholangiocarcinoma mortality in the USA, 1999-2020: a 21-year population-based analysis
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Intrahepatic cholangiocarcinoma (ICC) mortality is rising in the USA. This study highlights significant disparities in ICC deaths across demographics and regions, emphasizing the need for targeted public health strategies.
Area Of Science
- Oncology
- Public Health
- Epidemiology
Background
- Intrahepatic cholangiocarcinoma (ICC) is an aggressive liver cancer with a poor prognosis.
- Mortality rates for ICC have been increasing globally and within the USA.
Purpose Of The Study
- To analyze national trends in ICC-related mortality in the USA from 1999 to 2020.
- To identify demographic and regional disparities in ICC mortality.
Main Methods
- Utilized CDC WONDER data for ICC mortality from 1999-2020.
- Employed joinpoint regression analysis to assess age-adjusted mortality rates (AAMR) and annual percentage change (APC).
- Stratified trends by age, gender, race/ethnicity, and geographic location.
Main Results
- Overall ICC AAMR increased from 0.98 to 2.04 per 100,000 population (APC 3.55).
- Higher mortality observed in males, Non-Hispanic Asian/Pacific Islanders, and individuals aged 85+.
- Significant regional variations noted, with higher rates in specific states and metropolitan areas.
Conclusions
- ICC mortality shows a consistent upward trend in the USA.
- Substantial demographic and geographic disparities in ICC mortality exist.
- Findings underscore the necessity for targeted public health interventions and improved early detection strategies.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...